Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis [NA]

View source ↗

Summary

A clinical trial evaluated the safety and efficacy of apremilast for skin involvement in dermatomyositis. The study was terminated and results were posted in Ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Drugs mentioned

• OTEZLA (apremilast)

Snippet

Sponsor: Stanford University | Conditions: Dermatomyositis | NA | Status: TERMINATED | Results posted: 2015-03-04